Use of Phosphatide Precursors to Promote Synaptogenesis
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
New brain synapses form when a postsynaptic structure, the dendritic spine, interacts with a presynaptic terminal. Brain synapses and dendritic spines, membrane-rich structures, are depleted in Alzheimer's disease, as are some circulating compounds needed for synthesizing phosphatides, the major constituents of synaptic membranes. Animals given three of these compounds, all nutrients—uridine, the omega-3 polyunsaturated fatty acid docosahexaenoic acid, and choline—develop increased levels of brain phosphatides and of proteins that are concentrated within synaptic membranes (e.g., PSD-95, synapsin-1), improved cognition, and enhanced neurotransmitter release. The nutrients work by increasing the substrate-saturation of low-affinity enzymes that synthesize the phosphatides. Moreover, uridine and its nucleotide metabolites activate brain P2Y receptors, which control neuronal differentiation and synaptic protein synthesis. A preparation containing these compounds is being tested for treating Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Function and regulation of CREB family transcription factors in the nervous system
Lonze, B. E., & Ginty, D. D. (2002) · Neuron · doi:10.1016/s0896-6273(02)00828-0 · Cited by 2,127 · cited 1×
“Synaptogenesis can also be enhanced by the activation of neuronal genes, for example, those for transcription factors like CREB (cAMP response element-binding protein), which enhances synapse formation (2, 93, 108), and for myocyte enhancer factor 2, which limits the potentially excessive formation of new synapses (13…”
BackgroundPhysiological concentrations of purines and pyrimidines
Traut, T. W. (1994) · Molecular and Cellular Biochemistry · doi:10.1007/bf00928361 · Cited by 1,867
Abel, T., Nguyen, P. V., Barad, M., Deuel, T. A. S., Kandel, E. R., & Bourtchouladze, R. (1997) · Cell · doi:10.1016/s0092-8674(00)81904-2 · Cited by 1,217 · cited 1×
“Synaptogenesis can also be enhanced by the activation of neuronal genes, for example, those for transcription factors like CREB (cAMP response element-binding protein), which enhances synapse formation (2, 93, 108), and for myocyte enhancer factor 2, which limits the potentially excessive formation of new synapses (13…”
BackgroundLTP promotes formation of multiple spine synapses between a single axon terminal and a dendrite
Toni, N., Buchs, P.-A., Nikonenko, I., Bron, C. R., & Muller, D. (1999) · Nature · doi:10.1038/46574 · Cited by 949 · cited 1×
“The formation of dendritic spines in the hippocampus is induced physiologically by synaptic inputs that induce long-term potentiation in CA1 pyramidal neurons, probably mediated by enhanced calcium influx into the postsynaptic neuron (55, 178).”
BackgroundGhrelin controls hippocampal spine synapse density and memory performance
Diano, S., Farr, S. A., Benoit, S. C., McNay, E. C., da Silva, I., Horvath, B., Gaskin, F. S., Nonaka, N., Jaeger, L. B., Banks, W. A., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1656 · Cited by 828 · cited 2×
“A number of treatments apparently can increase dendritic spines, for example, giving the hormone ghrelin to mice caused parallel increases in the density of hippocampal dendritic spines and in memory performance and long-term potentiation; in contrast, targeted disruption of the gene for ghrelin in other mice decrease…”
BackgroundEarly-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease
Jacobsen, J. S., Wu, C.-C., Redwine, J. M., Comery, T. A., Arias, R., Bowlby, M., Martone, R., Morrison, J. H., Pangalos, M. N., Reinhart, P. H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600948103 · Cited by 701
Fatty acid composition of brain phospholipids in aging and in Alzheimer’s disease
Söderberg, M., Edlund, C., Kristensson, K., & Dallner, G. (1991) · Lipids · doi:10.1007/bf02536067 · Cited by 667 · cited 1×
“Brains of patients with Alzheimer’s disease are deficient in choline (128) and in DHA (166) and exhibit selective decreases in numbers of P2Y2 receptors (100) and dendritic spines (97) and synapses (175).”
BackgroundSynapse formation on neurons born in the adult hippocampus
Toni, N., Teng, E. M., Bushong, E. A., Aimone, J. B., Zhao, C., Consiglio, A., van Praag, H., Martone, M. E., Ellisman, M. H., & Gage, F. H. (2007) · Nature Neuroscience · doi:10.1038/nn1908 · Cited by 579 · cited 2×
“Their numbers in particular brain regions are highly correlated with numbers of synapses (5, 7, 8, 13, 52, 53, 72, 98), and it has been proposed (179) that “more than 90% of excitatory synapses occur on dendritic spines.”
BackgroundActivity-Dependent Regulation of MEF2 Transcription Factors Suppresses Excitatory Synapse Number
Flavell, S. W., Cowan, C. W., Kim, T.-K., Greer, P. L., Lin, Y., Paradis, S., Griffith, E. C., Hu, L. S., Chen, C., & Greenberg, M. E. (2006) · Science · doi:10.1126/science.1122511 · Cited by 573
Spine growth precedes synapse formation in the adult neocortex in vivo
Knott, G. W., Holtmaat, A., Wilbrecht, L., Welker, E., & Svoboda, K. (2006) · Nature Neuroscience · doi:10.1038/nn1747 · Cited by 563 · cited 1×
“Their numbers in particular brain regions are highly correlated with numbers of synapses (5, 7, 8, 13, 52, 53, 72, 98), and it has been proposed (179) that “more than 90% of excitatory synapses occur on dendritic spines.”
Background
Cited by
Choline and betaine in health and disease
Ueland, P. M. (2011) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9088-4 · Cited by 576
Janssen, C. I. F., & Kiliaan, A. J. (2014) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.10.002 · Cited by 514
Ethanolamine and Phosphatidylethanolamine: Partners in Health and Disease
Patel, D., & Witt, S. N. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/4829180 · Cited by 358
APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia
Sienski, G., Narayan, P., Bonner, J. M., Kory, N., Boland, S., Arczewska, A. A., Ralvenius, W. T., Akay, L., Lockshin, E., He, L., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz4564 · Cited by 336
“Choline (trimethylamine) serves as the head group for phosphatidylcholines and sphingomyelins and functions as a signaling molecule and methyl donor (59).”
BackgroundEfficacy of Souvenaid in Mild Alzheimer's Disease: Results from a Randomized, Controlled Trial
Scheltens, P., Twisk, J. W. R., Blesa, R., Scarpini, E., von Arnim, C. A. F., Bongers, A., Harrison, J., Swinkels, S. H. N., Stam, C. J., de Waal, H., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-121189 · Cited by 306
Self-citation
Metadata
- Authors
- Wurtman, R. J., Cansev, M., Sakamoto, T., & Ulus, I. H.
- Venue
- Annual Review of Nutrition
- Publisher
- Annual Reviews
- Published
- 2009-08-01
- Volume
- 29
- Issue
- 1
- Pages
- 59-87
- ISSN
- 0199-9885 (ISSN-L)
- 1545-4312
- OpenAlex
- W2154551343
- Cited by
- 130
- References
- 19
- FWCI
- 1.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of Phosphatide Precursors to Promote Synaptogenesis. https://app.cochat.ai/papers/10.1146/annurev-nutr-080508-141059
- The paper
- Wurtman, R. J., Cansev, M., Sakamoto, T., & Ulus, I. H. (2009). Use of Phosphatide Precursors to Promote Synaptogenesis. Annual Review of Nutrition. https://doi.org/10.1146/annurev-nutr-080508-141059
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.